Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Burmese pythons in Florida are devouring animals as small as rabbits and as big as deer and alligators. How they do it is fascinating and unsettling.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In 2026, most companies are using AI in some fashion, as companies feel pressure to keep up with competitive industry dynamics and experiment with the new technology. The stocks on this list were ...